Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.15B | $19.07B | $23.81B | $17.36B | $17.34B | $18.57B | $18.67B | $18.44B |
| Cost of revenue | $11.34B | $11.86B | $16.78B | $10.37B | $10.77B | $11.81B | $12.57B | $10.60B |
| Gross profit | $7.82B | $7.21B | $7.04B | $6.99B | $6.57B | $6.76B | $6.09B | $7.84B |
| Gross margin | 40.8% | 37.8% | 29.6% | 40.3% | 37.9% | 36.4% | 32.6% | 42.5% |
| Selling, general and administrative | $0 | $0 | $13.86B | — | $0 | $0 | $13.02B | — |
| Operating expenses | $18.12B | $17.58B | $22.51B | $16.31B | $16.36B | $17.25B | $17.12B | $16.58B |
| Operating income | $1.04B | $1.49B | $1.30B | $1.05B | $980.00M | $1.32B | $1.55B | $1.86B |
| Operating margin | 5.4% | 7.8% | 5.5% | 6.1% | 5.7% | 7.1% | 8.3% | 10.1% |
| EBITDA | $783.00M | $1.49B | −$443.00M | $1.05B | $708.00M | $1.32B | −$568.00M | $1.86B |
| Income before taxes | $1.04B | $1.51B | $1.12B | $1.21B | $980.00M | $1.35B | $1.38B | $1.99B |
| Income taxes | $256.00M | $345.00M | $301.00M | $308.00M | $245.00M | $404.00M | $106.00M | $653.00M |
| Net income | $779.00M | $1.16B | $816.00M | $902.00M | $735.00M | $950.00M | $1.28B | $1.34B |
| Net margin | 4.1% | 6.1% | 3.4% | 5.2% | 4.2% | 5.1% | 6.8% | 7.3% |
| EPS, basic | $1.10 | $1.75 | $1.18 | $1.23 | $1.04 | $1.29 | $1.79 | $1.82 |
| EPS, diluted | $1.09 | $1.74 | $1.18 | $1.22 | $1.03 | $1.28 | $1.78 | $1.81 |
| Diluted shares | 646.90M | 655.70M | 662.10M | 669.10M | 675.00M | 687.00M | 697.60M | 703.70M |
Figures describe MetLife shares, not any token. As of Aug 6, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.